Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real-world conditions in Germany - The non-interventional study NIELS.
R GutzmerH-J SchulzeAxel HauschildUlrike LeiterFriedegund MeierS HaferkampC UlrichR U WahlCarola BerkingR HerbstM HäcklDirk SchadendorfPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
The NIS NIELS shows effectiveness and safety of vismodegib in patients with laBCC. It confirms the transferability of the results of the pivotal trial into routine clinical practice.